Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression
- 1Graduate Training Program in Immunology, University of Michigan Medical School, Ann Arbor, MI, USA
- 2Department of Internal Medicine-Rheumatology, University of Michigan Medical School, Ann Arbor, MI, USA
- 3Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
Schistosome worms have been infecting humans for millennia, but it is only in the last half century that we have begun to understand the complexities of this inter-relationship. As our sophistication about the inner workings of every aspect of the immune system has increased, it has also become obvious that schistosome infections have broad ranging effects on nearly all of the innate and adaptive immune response mechanisms. Selective pressures on both the worms and their hosts, has no doubt led to co-evolution of protective mechanisms, particularly those that favor granuloma formation around schistosome eggs and immune suppression during chronic infection. The immune modulatory effects that chronic schistosome infection and egg deposition elicit have been intensely studied, not only because of their major implications to public health issues, but also due to the emerging evidence that schistosome infection may protect humans from severe allergies and autoimmunity. Mouse models of schistosome infection have been extremely valuable for studying immune modulation and regulation, and in the discovery of novel aspects of immunity. A progression of immune reactions occurs during granuloma formation ranging from innate inflammation, to activation of each branch of adaptive immune response, and culminating in systemic immune suppression and granuloma fibrosis. Although molecular factors from schistosome eggs have been identified as mediators of immune modulation and suppressive functions of T and B cells, much work is still needed to define the mechanisms of the immune alteration and determine whether therapies for asthma or autoimmunity could be developed from these pathways.
Schistosoma mansoni, Schistosoma haematobium, and Schistosoma japonicum are helminth worm species that infect humans and are highly prevalent in warm climates. They are obligate parasites that require a supply of blood from mammalian hosts to mature from larval stages to adult worms. Schistosomes live within the body of their hosts where they attach to the walls of intestinal blood vessels for feeding. Adult male and female schistosomes form copulating pairs that can produce as many as 300 eggs per couple per day. The eggs only hatch in fresh water, and the first larval form requires the presence of freshwater snails in order to mature into cercariae, the larval form that infects humans and other mammals. Unfortunately, a large portion of the eggs that are produced enter the portal circulation instead of leaving the body and deposit in internal organs, particularly the liver. As will be described in more detail later in this review, the immune system of the host recognizes schistosome eggs as foreign and responds with a local granulomatous response and systemic changes to immunity. The ability of adult schistosome worms to persist in their hosts and the resulting continual production of eggs and their antigens drives the adaptive immune system toward a highly regulatory response that has repercussions to overall immunity.
Modeling of Schistosome Egg Granuloma Formation in Mice
Most of what is known about the mechanisms by which schistosome granulomas form and function has come from the use of mouse models, especially in response to Schistosoma mansoni eggs (Boros, 1989). Schistosome cercariae can infect most if not all mammalian hosts and mice have proven very useful for studying granulomatous responses due to significant similarities with the human immune system, the availability of a vast array of reagents, and the production of many immunogenetically altered mouse strains that aid in mechanistic studies. The classic model used to study granuloma formation involves infection with schistosome cercariae, the larval form that infects humans, either through skin exposure or direct subcutaneous injection into the mouse. Adult worm pairs produce eggs continuously resulting in asynchronous granuloma formation. The natural infection model has been very useful in the study of the dynamics of the immune response, pathology, and granuloma architecture, but has some limitations due to its asynchronous nature. To study temporal aspects of egg deposition and granuloma formation, other models were developed in which purified schistosome eggs, or egg antigens coated to beads or macromolecular compounds were injected into the tail veins of mice (Boros and Warren, 1971b). The intravenous injection model results in egg deposition primarily in the lungs, where the granulomas form simultaneously and temporal changes in the immune response can be more easily tracked. Differences have been noted between lung versus hepatic granulomas, and between the differing species of schistosome worms. Therefore, it is important to consider the route and form of administration, localization of granuloma formation, and the infectious agent when interpreting results.
The Schistosome Egg Granuloma: A Necessary Evil
Schistosome eggs have an outer shell made of chitin that houses the larval form, miracidiae, which is responsible for the release of soluble egg antigens (SEA). The miracidiae do not hatch in the host tissues, but production of SEA while the larvae are still viable stimulates the host immune response to form a granuloma (Boros and Warren, 1970). Using the temporal induction models, it was determined that the initial response to egg deposition and SEA release in small blood vessels involves the local production of inflammatory cytokines (TNFα, IL-1) and chemokines from resident epithelial cells and macrophages (Joseph and Boros, 1993; Lukacs et al., 1993; Wynn et al., 1993; Burke et al., 2010). This triggers the early influx of monocytes, neutrophils, and lymphocytes and the establishment of schistosome egg granulomas. Each schistosome egg and its individual granuloma do not pose much of a threat to the host. Over time, however, the constant deposition of eggs and formation of granulomas leads to hepatosplenomegaly and significant blockage of portal blood flow (Boros, 1989). Portal hypertension promotes the development of intestinal and esophageal varices resulting in severe bleeding and eventually can lead to the death of the infected individual. Schistosome egg granulomas were therefore viewed as major contributors to the pathogenesis of schistosome infection and strategies were sought to inhibit or prevent granuloma formation.
Several lines of evidence demonstrated that granuloma formation in response to SEA was dependent on the activation of CD4+ T helper (TH) lymphocytes and also highlighted the importance of granuloma formation to host survival. Infection of athymic nude mice led to substantially decreased granuloma size and impairment of the anti-SEA antibody response (Phillips et al., 1977; Amsden et al., 1980). Elimination of TH cells by treatment with anti-lymphocyte serum or the specific, complement-fixing anti-CD4 antibody, L3T4, led to decreased granuloma formation and IL-2 production by spleen cells of infected mice (Domingo and Warren, 1968; Mathew and Boros, 1986). The severe absence of granuloma formation following high efficiency anti-CD4-depletion in mice led to the influx of low numbers of macrophages or eosinophils, diminished collagen deposition around eggs and increased damage to local hepatocytes (Mathew and Boros, 1986; Fallon et al., 2000b). Further evidence of the critical importance of TH cell-mediated granuloma formation came from studies of infection in thymectomized mice and mice receiving additional T cell ablative therapies in which severe inhibition of granuloma formation led to mortality due to increased liver damage (Lucas et al., 1980; Fallon and Dunne, 1999). Toxicity to hepatocytes in the absence of granuloma formation has been attributed to the hepatotoxic cationic glycoproteins, α1 and ω1, released by schistosome eggs as part of SEA (Dunne et al., 1991; Abdulla et al., 2011). The mechanisms by which granulomas prevent direct hepatotoxicity have yet to be shown definitively, but of potential interest is a recent finding that the glycosylated T2 ribonuclease ω1 binds to the mannose receptor, a C-type lectin expressed by macrophages and dendritic cells (DC) (Dewals et al., 2010; Everts et al., 2012). Binding and internalization of ω1 through the mannose receptor on DC leads to polarization of these antigen presenting cells toward a TH2 inducing phenotype (Everts et al., 2009, 2012). Therefore, infiltration of macrophages and DC into granulomas in the liver appears to be one host protective mechanism for binding and neutralizing hepatotoxic glycans from the schistosome egg and surrounding tissue and for the ultimate survival of the host. At the same time, the response to ω1 by DC and macrophages drives the TH2 immune response leading to increased lymphocyte and eosinophil infiltration and enlargement of the granuloma (Everts et al., 2009; Steinfelder et al., 2009). As will be discussed below, this TH2 dominated response may also be an adaptive mechanism of protection of the host from deleterious prolonged TH1 mediated immunity. Chronic schistosome infection leads to further modulation of the immune response going from an acute TH2 reaction toward immune regulation and fibrosis.
Schistosome Granuloma Formation as A Dynamic Model of Adaptive Immune Responses
TH1 Cells Mediate Early Granuloma Formation
The role of TH cell-derived cytokines in schistosome granuloma formation has been intensively studied and reviewed (Scott et al., 1989; Boros, 1994; Milner et al., 2010). A timeline of the changes in mouse TH cell responses during the natural infection by schistosome cercariae is given in Figure 1. Following the initial proinflammatory cytokine release, CD4+ TH cells enter the lesion and release TH1-type cytokines, IL-2 and IFNγ, which facilitates the establishment of delayed-type hypersensitivity response and early granuloma formation. A series of experiments led to the discovery of antigenic peptides, some that were able to induce TH1-type immune responses even in the absence of an adjuvant (Lukacs and Boros, 1991, 1992, 1993; Cai et al., 1996; Chen and Boros, 1998, 2001; Reis et al., 2008). The finding that neutralization of IL-4 during schistosome infection led to decreased granuloma formation prompted interest in prolonging TH1 responses during schistosome infection in order to reduce pathology (Yamashita and Boros, 1992). Initial results indicated that IL-12 could drive expression of IFNγ, IL-2, IL-10, and IL-12 in pulmonary granulomas and could reverse established TH2-type responses in egg pre-sensitized animals (Wynn et al., 1994). Further studies indicated that vaccination of mice with eggs plus IL-12 led to decreased fibrosis similar to that seen in Stat-6 knockout mice that lacked IL-4 receptor signaling (Wynn et al., 1995; Kaplan et al., 1998). Much of the IL-12 adjuvant effect was attributed to induction of IFNγ (Boros and Whitfield, 1998). However, extreme skewing of the immune response toward schistosome eggs to a TH1-type reaction resulted in increased mortality and liver pathology (Boros and Whitfield, 1998; Fallon and Dunne, 1999; Wynn and Hoffmann, 2000). In addition to the deleterious effects of an overt TH1-type response in mice, it has also been shown that the more severe form of human disease, hepatosplenic schistosomiasis, is associated with elevated levels of TNFα and IFNγ and lower levels of the TH2-type cytokine IL-5 (Mwatha et al., 1998). Thus, although decreased granuloma size and fibrosis in TH1 dominated responses appeared to be desirable, it is clear that the switch to a TH2-type response may have some protective effect for the host.
Figure 1. Timeline of TH cell mediated responses in the mouse model of schistosome infection. Subcutaneous injection of schistosome cercariae on day 0 leads to development of adult worms and egg production beginning at 4–5 weeks. The early innate and adaptive immune response to adult worm antigens is dominated by proinflammatory and TH1 cytokines (TNFα, IL-12, and IFNγ). Following egg deposition in the liver and other internal organs, the larval miracidiae release soluble egg antigens (SEA) containing molecules that drive a rapid transition from TH1 to TH2-dominated immunity and production of IL-4, IL-5, and IL-13. Between 7 and 8 weeks of infection, FoxP3+ TREG cells and IL-10 are detectable, and the population of splenic FasL+ CD5+ B cells begins to proliferate. TH2 response and peak granuloma formation occurs between 8 and 10 weeks of infection and is followed by granuloma downmodulation and increasing fibrosis around newly deposited eggs which persists throughout the remainder of infection.
TH2 Cells and Non-T Cell Sources of IL-4
In the murine model, the cytokine response to worm eggs and SEA begins to switch to a TH2-type response during the seventh week post-infection. By 8 weeks of infection, the production of IL-4 and other TH2 cytokines predominates and IFNγ is barely detectable. The switch to a TH2-type reaction is accompanied by a change in the cellularity of the granuloma with a dramatic influx of eosinophils, mast cells, and fibroblasts into the lesion. The influx of these cell types results in enlarged granulomas with increasing fibrosis. The mechanisms underlying this switch in cytokine pattern have been intensely studied. Neutralization of IL-4 or infection of IL-4-deficient or IL-4R-deficient mice leads to decreased TH2-type cytokine production and prolonged TH1 responses (Cheever et al., 1994; Kaplan et al., 1998; Jankovic et al., 1999). However, in certain murine strains, IL-4 deficiency was not enough to drive substantial increases in IFNγ production or to completely prevent development of a TH2-type response during infection (Metwali et al., 1996; Rakasz et al., 1998). IL-10 and/or TGF-β were the dominant mediators TH1 downregulation in IL-4 deficient mice (Rakasz et al., 1998). IL-4 deficient mice display reduced expression of IL-13, but the residual IL-13 may play a compensatory role for the loss of IL-4 expression (Chiaramonte et al., 1999b; McKenzie et al., 1999). IL-13 plays a similar role as IL-4 through binding to the IL-4 receptor and participates in granuloma formation, IgE induction, and inhibition of IFNγ production. In contrast to IL-4, IL-13 is also involved in the induction of collagen synthesis by granuloma fibroblasts through binding to the specific IL-13R (Chiaramonte et al., 1999a; Fallon et al., 2000a). TH1 and TH2 cytokines participate in cross-regulation of synthesis and function of the opposing cytokine response, therefore, it was initially unclear how the TH2 response could be induced while the TH1-type response that downregulates it was already actively mediating granuloma formation. One possibility is that IL-12 production from granuloma macrophages is decreased upon exposure to SEA (Boros, 1999; Todt et al., 2000).
Lacto-N-fucopentaose III (LNFPIII), a glycan component of SEA, has been shown to act directly on DC and monocytes to favor the development of the TH2 response (Wang et al., 2010; Zhu et al., 2012). In comparison to LPS stimulation, LNFPIII induced an increase in the ratio of CD86/CD80 expression on DC, a similar pattern of chemokine expression, higher expression of IL-6 but no IL-12 from purified DC (Wang et al., 2010). Co-culture of these LNFPIII-stimulated DC with naive OT-II TH cells led to dominant production of IL-4 and no IFNγ, but induced similar levels of IFNγ and cytolytic activity of OT-I CD8+ TC cells following co-culture in comparison with LPS-stimulated DC (Wang et al., 2010). LNFPIII was also shown to program macrophages to induce IFNγ production from NK cells by an IL-12-independent, but CD40/CD40L-dependent mechanism. Treatment with dextran conjugated to LNFPIII was successful at inhibiting experimental autoimmune encephalomyelitis (EAE) in mice through a mechanism involving alternative activation of CD11b+Ly-6Chigh monocytes (Zhu et al., 2012). The LNFPIII-treated TCR transgenic 2D2 mice had elevated levels of IFNγ as well as IL-4, IL-5, IL-13, and IL-10 in response to immunization with MOG peptide in comparison with mice that received unconjugated protein (Zhu et al., 2012). These data demonstrate alternate pathways by which LNFPIII elicits both IFNγ production from NK and CTL cells while also mediating a TH2 and TREG dominated responses from CD4+ T cells, and suggest a mechanism for the induction of TH2 cells in the face of a strong TH1 immune response. The T2 ribonuclease, ω1, component of SEA was demonstrated to directly inhibit the activation of DC by LPS, suggesting that it is a critical factor in the inhibition of the TH1 response (Everts et al., 2009; Steinfelder et al., 2009).
A study done using SEA stimulation of human basophils was one of the first in which IL-4 production by these cells was definitively shown (Falcone et al., 1996). Since that time it has become evident that basophils are not only capable of producing IL-4 but are also important antigen presenting cells that can initiate TH2 responses (Perrigoue et al., 2009; Sokol et al., 2009; Yoshimoto et al., 2009). The IPSE/α-1 glycoprotein component of SEA was shown to activate IL-4 production from mouse basophils through a mechanism dependent on IgE antibodies and FcΣR expression (Schramm et al., 2007). Several other groups have also demonstrated IL-4 production in response to SEA by non-CD4+ peritoneal exudate cells and activated granuloma eosinophils (Williams et al., 1993; Sabin and Pearce, 1995; Kullberg et al., 1996; Sabin et al., 1996b; Rumbley et al., 1999). IL-5 is a stimulatory cytokine for eosinophils and studies in IL-5 deficient mice have revealed a reduction in IL-4 production from ionomycin stimulated non-B, non-T cells from infected mice (Brunet et al., 1999). However, IL-4 production from SEA-stimulated or IgE crosslinked non-B, non-T cells of IL-5 deficient mice was comparable to normal mice and anti-IL-5 antibody treatment did not reduce granuloma sizes in infected mice (Sher et al., 1990). These non-T cell sources of IL-4 may be sufficient to supply the early IL-4 necessary to down regulate IL-12 and IFNγ production and to stimulate TH2 cell differentiation.
The Role of TH17 Cells in Granuloma Pathology
The first evidence of a role for IL-17 in schistosome granuloma formation came from a study in which blockade of the IL-12p40 receptor subunit shared by IL-12 and IL-23, but not the IL-12p35 receptor subunit that is specific to IL-12, led to decreased granuloma size (Rutitzky et al., 2005). Granuloma formation correlated with levels of IL-17 production in susceptible vs. resistant strains of mice and treatment of susceptible strains with anti-IL-17 neutralizing antibodies led to decreases in granuloma size (Rutitzky et al., 2005). It was later determined that SEA had direct stimulatory effects on IL-23 and IL-1 production by dendritic cells (Rutitzky et al., 2008; Shainheit et al., 2008). Mice with genetic deficiencies of the TH1-specific transcription factor T-bet or IFNγ displayed enlarged schistosome granulomas and elevated IL-17 levels (Rutitzky et al., 2009; Rutitzky and Stadecker, 2011). The studies described above were mostly performed using immunization with SEA and complete Freund's adjuvant in the normally granuloma resistant C57BL/6 strain of mice. IL-4 and type 1 interferons, which may be suppressed by instillation of complete Freund's adjuvant, are normally elicited by schistosome eggs and are known inhibitors of TH17 cells. It will be interesting to determine whether IL-4 and IFNα or IFNβ display inhibitory effects on IL-23 or IL-17 during schistosome infection in granuloma susceptible mice.
B Lymphocytes and Antibodies
The dynamics of total B cell distribution and their roles during schistosome infection have also been intensely investigated. It was found that the absolute numbers of B cells in the spleen, lymph nodes and blood increased dramatically during the acute TH2 phase of infection and remained high throughout the chronic infection (Chensue and Boros, 1979; El-Cheikh et al., 1998). The absolute number of T cells rose slightly in the same organs leading to a relative decrease in the number of T cells compared to B cells. This expansion of B cells was polyclonal in nature yielding both antigen-specific and non-specific antibodies, including autoreactive antibodies (Fischer et al., 1981; Lopes et al., 1990). SEA-specific immunoglobulin production begins following egg deposition and increases throughout the acute and chronic downmodulated phases of schistosome infection (Boros et al., 1975). Evidence of intra-granulomatous antibody production exists with IgG1 being the predominant antibody isotypes released from acute-phase granulomas and a mixture of IgG1, IgG2a, IgG2b, IgG3, and IgA released by chronic-phase granulomas (Boros et al., 1982). Intralesional production of IgM peaked at 12–16 weeks of infection while IgG production was highest at 20 weeks of infection (Boros et al., 1982). The role of antibodies in the pathogenesis of schistosome granuloma formation is complex, with several studies showing an active immune regulatory role of antibodies from infected individuals (Goes et al., 1991; Jankovic et al., 1997, 1998; Rezende et al., 1998). Immune complexes from the blood of chronically infected human patients were able to inhibit in vitro granuloma formation (Goes et al., 1991). This inhibition was dependent on the presence of the Fc portion of the immunoglobulin and could be reversed by treatment with indomethacin, indicating a role for prostaglandins in immune suppression mediated by immune complexes (Goes et al., 1991). Infection of mice deficient in either FcγR or FcΣR led to increased size and collagen content of acute-phase and chronic granulomas (Jankovic et al., 1997, 1998). SEA-specific antibodies may mediate granuloma downmodulation by arming FcR positive suppressor cells, or by neutralizing and sequestering antigens. Another mechanism by which immune complexes may mediate downmodulation is through inhibition of MHC Class II expression and disruption of antigen presentation (Rezende et al., 1998).
Several lines of evidence suggest that immune regulation and control of granuloma formation may be the primary function of B cells during schistosome infection. One study demonstrated that SEA-stimulated mesenteric lymph node cells of B cell-deficient (JHD) mice produced higher amounts of IFNγ and IL-12 cytokines and reduced amounts of IL-4 and IL-10 when stimulated with SEA (Hernandez et al., 1997). Irradiated splenocytes from JHD mice were more effective at eliciting a TH1-type response from SEA-specific CD4+ T cells. Another study in B cell-deficient (μMT) mice showed increased mRNA expression of TH1 cytokines in B-deficient compared to wild-type mice (Ferru et al., 1998). These authors concluded that the B cell population was necessary to drive TH2-type responses during infection. However, a different study using μMT mice demonstrated only a reduction in IL-4 production without differences in IL-5, IL-10, or IFNγ production (Jankovic et al., 1998). In contrast, infection of BALB.Xid mice, which have a deficiency in B cell receptor signaling and severe reductions in the mucosal CD5+ B cell compartment, revealed a defect in antigen-stimulated IL-10 production, reduced SEA-specific IgM and IgA titers, increased IFNγ and IL-4 production, elevated IgE and IgG1 titers, increased tissue egg burdens and higher mortality (Gaubert et al., 1999). Thus, B cells appear to play a central role in mediating the transition from TH1 to TH2 responses and in the regulation of the granulomatous response during acute and chronic infection. Antibody-independent regulatory mechanisms of B cells are discussed below.
Systemic Immune Regulation Stimulated by Chronic Schistosome Infection
As the TH2 response progresses, SEA-induced and cytokine-mediated collagen synthesis by granuloma fibroblasts leads to increased hepatic fibrosis that continues through the remainder of infection (Boros and Lande, 1983). Schistosome granulomas reach peak size and cellularity at 8–10 weeks of natural murine infection. After 10 weeks, a spontaneous diminution of cytokine responses to SEA and decreased granuloma size (granuloma downmodulation) is observed leading to a less severe chronic stage of the murine disease by 14 weeks (Boros et al., 1975; Colley, 1975). Downmodulation is accompanied by cumulative hepatic fibrosis and elevated anti-SEA antibody titers (Boros et al., 1975). Splenectomy of infected mice at 8 weeks of infection led to increased granuloma size at 12 weeks of infection indicating that a splenic mechanism was involved in granuloma downmodulation (Hood and Boros, 1980). Subsequent studies were directed at identifying the splenic factor(s) involved in granuloma downmodulation.
The earliest findings showed that spleen cells from chronically infected mice were able to transfer downmodulation to acutely infected mice (Colley, 1976; Chensue and Boros, 1979). Depletion of T cells from spleen cell preparations demonstrated their role in transferring downmodulation (Chensue and Boros, 1979). A complex series of experiments followed in which the granuloma inducing properties of T cells were attributed to TH cells, while granuloma and SEA-induced suppressive effects were attributed to both the TH and CD8+ cytotoxic T lymphocyte (CTL) subsets (Chensue et al., 1981; Weinstock and Boros, 1983; Ragheb and Boros, 1989; Fidel and Boros, 1990). However, a subsequent study of infection in CTL-deficient mice demonstrated normal granuloma formation during acute infection and normal downmodulation during chronic infection (Yap et al., 1997). These data suggested that although highly purified CTL were capable of regulating granuloma formation, their presence in vivo was not critical for controlling the immune response toward schistosome eggs. This indicated the importance of CTL-independent factors in mediating granuloma downmodulation that are now understood to involve the activation of regulatory populations of T and B lymphocytes as well as other mechanisms of immune suppression.
Regulatory Cytokines: IL-10 and TGF-β
The anti-inflammatory cytokine product of regulatory lymphocytes, IL-10, was recognized as an important mediator of the switch from TH1- to TH2-type response during schistosomiasis in the early 1990s (Sher et al., 1991; Oswald et al., 1992b). As is now a widely recognized property of IL-10, early neutralization studies led to increased MHC Class II and B7-1/B7-2 costimulatory molecule expression on granuloma macrophages and increased antigen presentation capacity for TH1 cells (Flores Villanueva et al., 1993). In a subsequent study, recombinant IL-10 or IL-10/Fc fusion protein treatment of infected or egg-injected mice led to decreased granuloma formation, decreased IL-2 and IFN-γ production, and increased IL-4 and IL-10 production (Flores-Villanueva et al., 1996). In one study, mice treated with anti-IL-10 antibodies in vivo displayed increased hepatic and pulmonary granuloma size, increased eosinophilia, and elevated IFN-γ and IL-5 levels during acute infection (Boros and Whitfield, 1998). However, another study indicated that granuloma downmodulation was not impaired in IL-10 deficient mice (Wynn et al., 1998). The same group also showed that infections of IL-10/IL-4 and IL-10/IL-12 double deficient mice in comparison to mice with singular deficiencies led to severe immune polarizations to TH1 and TH2, respectively (Wynn et al., 1997). The double deficient mice died from very distinct pathologic mechanisms with the IL-10/IL-12 mice that were heavily skewed toward the TH2 response having enlarged and highly fibrotic granulomas (Wynn et al., 1997; Hoffmann et al., 2000). These data indicated that IL-10 regulates the TH2 as well as the TH1 response toward schistosome antigens. Production of IL-10 in response to stimulation with SEA or its major glycan component, lacto-N-fucopentaose III (LNFPIII), has been attributed to TH cells, B cells and monocytes (Sher et al., 1991; Velupillai et al., 1996a, 1997; Terrazas et al., 2001).
The role of TGFβ in granuloma pathology is even more complex than that of IL-10. TGFβ has an inhibitory effect on macrophages and TH1 cells in the schistosome model (Oswald et al., 1992a; Qadir et al., 2001). Studies of inhibition of TH cell responses and schistosome granuloma formation by TGFβ have the limitation that IL-10 and IL-4 were usually present (Oswald et al., 1992a; Qadir et al., 2001). In contrast, TGFβ in the context of proinflammatory cytokines acts as an important cofactor for TH17 cell differentiation, and therefore, can contribute to the enhanced granuloma formation described in a previous section (Shainheit et al., 2008). TGFβ also induces the production of connective tissue components by fibroblasts and therefore may play a role in the development of fibrosis and portal hypertension seen in severely infected individuals (Wahl et al., 1997).
Regulatory T Lymphocytes
With the discovery that FoxP3 was the canonical transcription factor for regulatory T (TREG) cells that produced IL-10 and TGFβ, it was of interest to study whether the previously observed effects of chronic granuloma-induced immune suppression were attributable to TREG cells (Hori et al., 2003). In the natural infection model with S. mansoni, dramatic and progressive increases in the expression of FoxP3 mRNA were observed in the liver and spleen, with peak expression occurring at the 16 week granuloma downmodulated stage and highest in the liver (Singh et al., 2005; Taylor et al., 2006). Additional phenotypic markers of TREG cells (CD103, GITR, OX40, and CTLA-4) were also elevated at the mRNA level in the spleens of schistosome-infected mice (Layland et al., 2010). Over-expression of FoxP3 through retroviral gene transfer at the beginning of egg deposition resulted in increased expression of IL-4, IFNγ, and TGFβ but not IL-10, yet resulted in decreased granuloma formation (Singh et al., 2005). The expansion but low IL-10 expression of FoxP3+ TREG cells was also observed in a separate study of the natural infection model (Baumgart et al., 2006). Transfer of immune tolerance by TREG derived from schistosome infected hosts was IL-10 independent (Pacifico et al., 2009). These data demonstrate that TREG cells are activated and recruited by the schistosome granuloma, but that they are not necessarily the main source of IL-10 during infection, nor are they dependent on IL-10 for their immune suppressive functions.
Regulatory B Lymphocytes
The realization that B cells have regulatory capacity was initially demonstrated in response to sheep red blood cells and was associated first with regulatory antibody production and later linked to interactions with T cells (Stockinger et al., 1979; Zubler et al., 1980). Subsequent studies in mice and humans have demonstrated that B lymphocytes can regulate immune responses through antibody-dependent mechanisms as well as via direct cell–cell interactions and regulatory cytokine production (Klinker and Lundy, 2012). The schistosome granuloma model was one of the first natural infection models in which the regulatory properties of B lymphocytes were reported (Cheever et al., 1985). Mice that were genetically deficient in B cells failed to downmodulate granuloma formation around eggs deposited in the liver during chronic infection and had higher mortality rates than control mice with normal B cell development (Cheever et al., 1985). The regulatory properties of B cells in schistosome infection were originally attributed to the increased production of natural antibodies, which more recently have been demonstrated to play a role in the clearance of apoptotic cell debris and immune suppression (Chen et al., 2009; Vas et al., 2012). In addition, it was demonstrated that IL-10 production by B cells, particularly the CD5+ B-1a cell subset, was induced in vitro by the schistosome glycan LNFPIII found in SEA (Velupillai and Harn, 1994; Velupillai et al., 1996a, 1997). A study of schistosome infection in Xid mice, which have a severe deficiency in CD5+ B cells, demonstrated that this subset plays a role in regulating the production of IFNγ and IL-5 by TH cells and in controlling granuloma size (Gaubert et al., 1999). IL-10 acts as an autocrine growth factor for CD5+ B cells and both IL-12 and IFNγ inhibit the expansion of CD5+ B cells during schistosome infection (Velupillai et al., 1996b). Redistribution of splenic CD5+ B cells to Peyer's patches and mesenteric ganglia during schistosome infection has been reported, and may be one mechanism by which helminth infections regulate inflammatory bowel disease (El-Cheikh et al., 1998; Elliott et al., 2000).
Although most subsets of APC can produce IL-10 in response to stimulation through CD40 and toll-like receptors, two subsets of B cells have been identified as the major producers of IL-10 in mice, B10 and T2-MZP B cells (Evans et al., 2007; Yanaba et al., 2008). B10 cells have the surface phenotype CD5+CD1dhigh and may be the cells that responded to stimulation with schistosome LNFPIII in the previous study (Velupillai et al., 1997; Yanaba et al., 2008). Stimulation of IL-10 production by T2-MZP cells, which have the phenotype CD21highCD23+, has not yet been studied during schistosome infection. B10 and T2-MZP cells have been used to transfer immune suppression in several models of inflammation in mice, and work is being done to identify the equivalent of IL-10 producing B10 and T2-MZP cells in human peripheral blood (Blair et al., 2010; Iwata et al., 2011). Importantly, the regulatory responses induced by B10 and T2-MZP cells appear to be antigen specific, despite being linked primarily to IL-10 production, suggesting the requirement for antigen presentation in their regulatory function. A recent study demonstrated IL-10 producing CD1dhigh B cells from the spleens of schistosome infected mice could transfer immune regulation in a mouse model of ovalbumin-induced asthma (Van Der Vlugt et al., 2012). A similar population of B cells was found to be prevalent in the peripheral blood of children infected with S. haematobium in Gabon (Van Der Vlugt et al., 2012). The effect of schistosome infection on responses to other infections and inflammatory stimuli will be discussed in greater detail in another section.
Activation-Induced Cell Death and FasL+ B Lymphocytes
Interestingly, the CD5+ B cells in schistosome-infected mice also expressed Fas ligand and were able to kill SEA-stimulated TH cells by activation-induced cell death (AICD) (Lundy and Boros, 2002). AICD is a form of programmed cell death (apoptosis) that is an important mechanism of immune regulation during and after inflammatory reactions. Clusters of apoptotic cells were found in the spleens and granulomas of schistosome infected mice to a much greater extent than in spleens of uninfected mice (Estaquier et al., 1997). Culture of cells extracted from schistosome-infected mice demonstrated that CD4+ and CD8+ T cells spontaneously underwent apoptosis in vitro and were sensitive to apoptosis induction in response to IL-10 and mitogenic stimulation (Estaquier et al., 1997). A different study demonstrated increases in in vivo CD4+ and CD8+ T cell apoptosis from 4 to 7 weeks of infection compared to later time points, supporting the hypothesis that TH1 cells were more susceptible to AICD than their TH2 counterparts during schistosome infection (Fallon et al., 1998). In contrast, a study of human schistosomiasis indicated that T cells from patients with the less severe, intestinal form of disease were susceptible to apoptosis while T cells from patients with the more severe, hepatosplenic TH1 form of disease were resistant to egg antigen-induced apoptosis (Carneiro-Santos et al., 2000). In a more prolonged model of natural murine Schistosoma mansoni infection, systemic sensitivity to TH cell apoptosis commenced soon after egg deposition (5 weeks), and progressed throughout the early granulomatous stages (6–10 weeks), in parallel with increased inflammation, and persisted at lower levels throughout the chronic, downmodulated stage (12–16 weeks) of the infection (Lundy et al., 2001). Levels of apoptosis exceeded 20% of the total CD4+ T cell population, which was far in excess of the expected number of antigen-specific cells, suggesting that a large number of bystander CD4+ T cells may be eliminated during schistosome infection (Lundy et al., 2001). Culture of splenocytes from infected and uninfected mice with SEA led to TH cell apoptosis only in cells isolated from infected mice (Lundy et al., 2001). The three major lymphocyte populations of the spleen, CD4+ and CD8+ T cells as well as CD19+ B cells expressed the death-inducing molecule Fas ligand (FasL, CD178) (Lundy et al., 2001). The staining of freshly isolated splenocytes from 5 to 16 weeks infected mice demonstrated that the number of surface FasL+ cells correlated with the level of TH cell apoptosis at each time point (Lundy et al., 2001).
FasL expression on CD8+ and CD4+ T cells is not surprising given that both T cell recognition of schistosome antigens and FasL up-regulation are mediated through the TCR. FasL expression by B cells was a much rarer finding, and the schistosome model provided some of the first evidence of the ability of isolated B lymphocytes to kill TH cells in an SEA-dependent fashion (Lundy et al., 2001; Lundy and Boros, 2002; Lundy, 2009). Culture of splenocytes from 8 week-infected mice with SEA led to upregulated FasL expression on B and T cells and increased TH cell apoptosis. Depletion studies indicated that the majority of TH cell death was mediated by B cells rather than CD8+ CTL (Lundy et al., 2001). In a follow up study, B cell FasL expression was observed primarily on the splenic CD5+ B cell subset throughout schistosome infection and was even observed on splenic CD5+ B cells in uninfected mice (Lundy and Boros, 2002). Purified CD5+ B cells killed TH cells from schistosome-infected mice at a low effector:target (0.5:1) ratio only when SEA was present (Lundy and Boros, 2002). FasL expression on CD5+ B cells was stimulated by culture with SEA and further enhanced when IL-4 and/or IL-10 were added to the culture (Lundy and Boros, 2002). The induction of IL-10 production by CD5+ B cells following exposure to schistosome glycans may act in an autocrine manner to induce higher FasL expression on these cells and suggests that CD5+ B cells may have several mechanisms of immune suppression at their disposal (Velupillai et al., 1996a; Klinker and Lundy, 2012). Induced FasL expression and IL-10 production by CD5+ B cells, which are well-documented to have autoreactive and poly-reactive antibody specificities, may be an important mechanism behind the correlations between schistosome infection and protection from autoimmunity and asthma described below (Lundy et al., 2005; Lundy and Fox, 2009).
Other Mechanisms of Immune Regulation
Other cell types may also participate in downregulation of the immune response to schistosome eggs. Granuloma macrophages represent about 30 percent of the total cells in the lesion. Early in the response to infection, macrophages and monocytes are important in the elicitation of delayed-type hypersensitivity granuloma formation and have cytotoxic effects on the miracidiae (Boros and Warren, 1971a). However, as described above, exposure to components of SEA results in alternative activation of monocytes and macrophages as well as DC, and promotion of the transition to a TH2 dominated immune response (Zhu et al., 2012). In addition, exposure of monocytes/macrophages to SEA leads to suppressive effects on SEA-induced T lymphocyte proliferation (Elliott and Boros, 1984). These macrophage suppressive effects may be attributable to SEA-induced production of IL-10, type 1 interferons and/or prostaglandin E2 (Elliott et al., 1987, 1990; Atochina and Harn, 2005). An interesting study of the effects of schistosome infection on chemically-induced experimental colitis in mice demonstrated an immune regulatory effect of F4/80+ macrophages that had migrated to the lamina propria (Smith et al., 2007). These macrophages were not induced by injection of schistosome eggs alone, and their mechanism of action was reported to be independent of alternative activation markers, interactions with TH2 and TREG cells, or production of TGFβ or IL-10 (Smith et al., 2007). Schistosome infection also induces production of IL-10 by DC that in turn can induce the activation of FoxP3+ TREG cells (Liu et al., 2011). These schistosome-induced DC transferred resistance to airway inflammation following adoptive transfer in an ovalbumin-induced model of asthma (Liu et al., 2011). Similar IL-10 production by DC and DC-dependent induction of TREG cells was found following schistosome infection in the NOD mouse model of type 1 diabetes (Zaccone et al., 2009).
Schistosome Infection Modulates Immune Responses Toward Other Antigens
The systemic immune modulatory and regulatory pathways elicited by schistosome infection are not limited to antigens produced by adult schistosomes or their eggs (Harnett and Harnett, 2006; Helmby and Bickle, 2006; Kamal and El Sayed Khalifa, 2006; Zaccone et al., 2006). Bystander immune modulation by helminths has become a topic of great interest because of its negative impact on responses to vaccinations and pathogenic co-infections (Kamal and El Sayed Khalifa, 2006). With over 200 million estimated cases of schistosome infection worldwide, diminished responsiveness to protective vaccines and pathogenic infections poses a major public health hurdle, and justifies the support for global initiatives aimed at reducing schistosome infection (Borkow and Bentwich, 2000). Yet, as will be discussed, schistosomes and other helminths have been correlated to protection from allergies and autoimmunity by many epidemiological studies as well as experimental model systems and clinical trials (Kamal and El Sayed Khalifa, 2006; Zaccone et al., 2006; Maizels, 2009).
Responses to Vaccinations and Concurrent Infections
The switch from TH1- to a strong TH2-dominated immune response that occurs during progression of schistosome infection and egg granuloma formation has a negative impact on the ability of the host to respond correctly to intracellular pathogens. As the infection becomes more chronic, the TH2 response gives way to a highly regulatory immune response that can dampen both TH1 and TH2 immunity, leaving the host very susceptible to both intracellular and extracellular microbes. While this progression may be necessary to regulate liver toxicity and granuloma formation caused by the schistosome eggs (see above), it also causes significant morbidity and increased mortality in infected individuals. Schistosome infection has been shown to have preventive effects on immune responses elicited by vaccines against tetanus toxoid in humans and diphtheria toxin as well as Bacillus-Calmette-Guérin in mice (Sabin et al., 1996a; Haseeb and Craig, 1997; Elias et al., 2005). These examples illustrate altered humoral and cellular immune responses toward vaccines and will most likely translate to many other types of vaccinations including those against HIV, hepatitis viruses, Mycobacteriae spp. and malaria, significant pathogens that coexist in schistosome endemic areas.
The interaction between schistosome and HIV infections is of particular importance as the overlapping endemic regions for these two infections persist. Cells from schistosome infected individuals are more susceptible to HIV-1 infection reportedly due to IL-4 or IL-10 induced expression of the HIV co-receptors CXCR4 and CCR5 on immune cells of schistosome infected subjects (Shapira-Nahor et al., 1998; Kalinkovich et al., 1999; Secor et al., 2003). Selective inhibition of the cytolytic response of CD8+ T cells for the HIV Gag protein has also been noted in schistosome infected individuals (McElroy et al., 2005). These findings could be expected to increase cell–cell transmission and viremia in individual patients, and therefore, to increase the person to person transmission of HIV in schistosome endemic areas (Quinn et al., 2000). However, studies of HIV viral load and disease progression in schistosome infected individuals following de-worming have yielded conflicting results (Lawn et al., 2000; Wolday et al., 2002; Secor et al., 2004; Kallestrup et al., 2005). Susceptibility to HIV infection and response of the virus to de-worming is undoubtedly dependent on the stage and severity of the schistosome infection and the status of the immune response at the time of HIV exposure. In contrast, schistosome egg excretion is increased by T cell-mediated inflammation, and persons co-infected with HIV had marked decreases in the number of excreted eggs (Doenhoff, 1997).
Another major public health concern is co-infection of schistosome infected individuals with liver tropic viruses such hepatitis B and C (Kamal et al., 2004). Although there is evidence that schistosome infection does not increase the incidence of hepatitis infection in endemic areas for both diseases, co-infections in these regions are quite frequent (Larouze et al., 1987; Pereira et al., 1994; Angelico et al., 1997). Interestingly, a study of liver biopsies of patients infected with hepatitis C showed no significant impact of co-infection by schistosomes or the presence of egg granulomas on virus-induced pathology (Helal et al., 1998). However, a separate study focused instead on the liver pathology of schistosome infected individuals, showed that co-infection with hepatitis C led to much more severe liver damage including cirrhosis and cancers that were not found in the absence of HCV co-infection (Mohamed et al., 1998). Despite the lack of evidence that schistosome co-infection changes the course of liver pathology caused by hepatitis virus, some studies have shown differences in TH cell cytokine responses toward viral antigens in schistosome co-infected people and viral persistence (Kamal et al., 2001; El-Kady et al., 2005). Schistosome co-infection suppressed the TH1 response normally elicited by HCV infection (Kamal et al., 2001; El-Kady et al., 2005). An improvement was seen in the anti-viral response of a cohort of co-infected patients following treatment with praziquantel to remove schistosomes (Farghaly and Barakat, 1993). In an experimental model of hepatic virus infection, schistosome infected mice co-infected with LCMV had an influx of activated CD8+ CTL cells expressing IFNγ into the liver, which led to down regulation of the granuloma TH2 response (Edwards et al., 2005). The end result of LCMV co-infection was increased liver toxicity and viral replication in the schistosome infected mice (Edwards et al., 2005). Thus, schistosomes and hepatotropic viruses have a complex relationship that generally leads to alterations in immune responses to both pathogens, and worse prognosis.
Schistosome infections can also influence the immune response toward other pathogens. Mice co-infected with Mycobacterium avium and Schistosoma mansoni had a shift to TH2 dominated cytokine responses toward mycobacterial antigens even when the M. avium infection was established first (Sacco et al., 2002). Similar results were seen in a co-infection model of S. mansoni and M. leprae in mice (Frantz et al., 2010). As noted above, schistosome infected mice responded poorly to vaccination with Bacillus-Calmette-Guerin, yet in the M. leprae study, vaccination with a DNA vaccine encoding the heat shock protein 65 molecule did induce a protective response in S. mansoni infected mice (Elias et al., 2005; Frantz et al., 2010). It remains to be seen whether such a strategy could be effective in co-infected humans, particularly those individuals who are also infected with the HIV virus. A study of the progression of active tuberculosis in HIV-infected individuals revealed a correlation between co-infection with schistosomes and increased active tuberculosis (Brown et al., 2006). A notable increase in susceptibility to malaria infection has also been described in people infected with schistosomes and other intestinal helminths (Nacher et al., 2002b; Sokhna et al., 2004). At the same time, schistosome infection may play a beneficial role in limiting the more severe cerebral form of malaria infection (Nacher et al., 2002a; Waknine-Grinberg et al., 2010). Co-infection of mice with Plasmodium chabaudi and S. mansoni led to reciprocal alterations in the immune response to either pathogen (Helmby et al., 1998). The widespread presence of schistosomes in areas that are endemic for these other major pathogens is likely to impede progress in designing effective vaccination and eradication strategies in the near future.
Schistosomes and the Hygiene Hypothesis
While major attempts at de-worming in schistosome endemic areas are important and worthwhile public health goals, there are substantial epidemiological and experimental data that indicate that this could lead to an increased risk for autoimmune diseases and allergy. The “hygiene hypothesis” asserts that the measurable increase in both TH1 and TH2 immune-mediated diseases that has occurred in the last century in developed nations is a result of improvements in sanitation that have led to increased sensitivity of the immune system to self-antigens and/or allergens (Gale, 2002; Airaghi and Tedeschi, 2004; Rook, 2012). Although the hygiene hypothesis was originally focused on the opposing roles of TH1 and TH2 immune responses that were established in childhood on later immune challenges, the hypothesis came under scrutiny when it was realized that both TH1 (type 1 diabetes) and TH2 (allergy) immune-mediated inflammatory diseases were rising in the same geographical areas and demographic groups (Stene and Nafstad, 2001). More telling was the fact that the prevalence of asthma and schistosome infections did not overlap despite both provoking heavily TH2-biased immune responses (Yazdanbakhsh et al., 2001). Now that it is understood that chronic helminth infections also stimulate a highly regulatory immune response that affects both TH1 and TH2 reactions, a role for schistosomes and other worms in the hygiene hypothesis fits better with the epidemiological data (Wynn et al., 1997; Araujo et al., 2004; Maizels, 2009). This intriguing correlation has led to series of experiments in mice as well as clinical trials to test the ability of helminths to modulate autoimmune diseases and asthma.
Autoimmune Diseases and Schistosomes
Type 1 diabetes (T1D) is an autoimmune disease that has risen in prevalence in developed and developing nations as hygiene has improved, and is rarely found in areas endemic for schistosomiasis (Zaccone et al., 2008). Cercarial infection of NOD mice that spontaneously develop T1D with Schistosoma mansoni prior to T1D disease development led to granuloma formation in the pancreas and a delay in hyperglycemia (Cooke et al., 1999). The same study showed that weekly injection of schistosome eggs led to suppression of anti-insulin IgG antibody production and decreased blood glucose levels in comparison to control NOD mice (Cooke et al., 1999). These effects were later shown to be dependent on the timing of administration and could be recapitulated by treatment with soluble antigens extracted from adult worms as well as with SEA (Zaccone et al., 2003). Splenic T cells from egg-sensitized NOD mice produced similar levels of IFNγ, but much higher amounts of IL-4, IL-5, IL-13, and IL-10 in response to SEA challenge than did cells from control mice (Zaccone et al., 2003). Unlike soluble antigens from adult worms, SEA cooperated with bacterial lipopolysaccharide (LPS) in mediating a shift away from IL-12 production and toward IL-10 production in bone marrow-derived DCs from NOD mice (Zaccone et al., 2003). Adoptive transfer of splenocytes from SEA-treated NOD mice failed to induce T1D in NOD. SCID recipients, an effect attributed to TGFβ-dependent induction of FoxP3+/GITR+/CD25+ TREG cells (Zaccone et al., 2003, 2009). Correlative studies involving schistosome infection have been reported in mouse models of Grave's disease and autoimmune arthritis (Nagayama et al., 2004; Osada et al., 2009; Song et al., 2011).
A series of experiments has been conducted in the EAE model of multiple sclerosis in which susceptible mouse strains are immunized with peptides derived from proteolipid protein or myelin oligodendrocyte glycoprotein emulsified in complete Freund's adjuvant. An initial study demonstrated that prior infection of mice with Schistosoma mansoni led to reduced incidence of EAE as measured by paralysis and delayed infiltration of CD3+ T cells and F4/80+ macrophages into the brain and spinal cord (La Flamme et al., 2003). These effects were attributed to reduced levels of TNFα, IFNγ and IL-12 produced by cells from schistosome-infected mice (La Flamme et al., 2003). Very similar results were obtained using schistosome eggs to pretreat mice prior to EAE disease induction (Sewell et al., 2003). In the latter study, egg injection within the first two days after induction of EAE led to a significant delay in the onset of paralysis but became less effective as the time after disease induction increased (Sewell et al., 2003). The EAE model can be mediated by either TH1 or TH17 cells, which are both sensitive to immune regulation by IL-4, and it was shown that the effects of schistosome eggs on EAE were dependent on the major signaling transcription factor downstream of IL-4 receptor, STAT6 (Sewell et al., 2003). Protection from EAE has also been demonstrated using either unfractionated SEA or purified LNFPIII derived from schistosome eggs (Zheng et al., 2008; Zhu et al., 2012). Despite the findings that a delay in exposure to schistosomes or their products can prevent therapeutic effects on EAE, the data in humans appears to be more promising. A small cohort of patients that had previously been diagnosed with MS and then developed eosinophilia related to intestinal helminth infection was identified in Argentina (Correale and Farez, 2007). These patients had significantly fewer exacerbations of MS upon 5-year follow up than matched control patients who were uninfected (Correale and Farez, 2007). The peripheral blood of the infected MS patients had a higher frequency of IL-10 and TGFβ producing cells than controls, and significantly reduced numbers of IL-12 and IFNγ producers (Correale and Farez, 2007). Further studies of this cohort indicated that IL-10 producing B cells were prevalent in the infected MS patients (Correale et al., 2008). B cells and DCs from infected patients expressed TLR2 at high levels and suppressed TH1 and TH17 cell cytokine production while promoting TH2 cytokines after treatment with TLR2 ligands (Correale and Farez, 2009).
It has also been suggested that the greatly increased incidence of the inflammatory bowel diseases (IBD), ulcerative colitis and Crohn's disease, in developed countries may be due to reduced exposure to helminths including Schistosoma mansoni (Weinstock and Elliott, 2009; Elliott and Weinstock, 2012). The gut mucosa is a site of exposure of the host to many potentially harmful microbes, as well as a majority of non-harmful commensal organisms. In order to maintain a balanced immune response in the gut mucosa, there are specialized lymphoid structures and cell populations that generally have a highly regulatory phenotype (Rubtsov et al., 2008; Maynard and Weaver, 2009). The development of IBD is known to be strongly suppressed by IL-10 and regulatory T cells as evidenced by animal models involving circumvention of these mechanistic pathways (Rubtsov et al., 2008; Glocker et al., 2009). As noted above, both IL-10-producing CD5+ B cells and FoxP3+ TREG cells are stimulated by infection with schistosomes. In particular, CD5+ B cells are normally resident in the mucosa and have high regulatory potential due to inducible expression of IL-10, FasL, regulatory natural antibodies and other mechanisms of immune regulation (Klinker and Lundy, 2012). Direct experimental evidence of a role for schistosome and other helminth infections in the suppression of IBD has come from experimental mouse models (Smith et al., 2007; Weng et al., 2007). Mice that were infected with cercariae 8 weeks prior to the elicitation of colitis in the dextran sodium sulfate (DSS) model did not display weight loss, bloody stools or shortening of colon length as was detected in uninfected control mice (Smith et al., 2007). In addition to induction of IL-10 and TGFβ, neither of which was solely responsible for protection from colitis, schistosome infection led to increased infiltration of macrophages into the intestinal lamina propria that were required for immune suppression (Smith et al., 2007). Although exposure to schistosome eggs did not elicit protection from orally-induced DSS colitis, this treatment was effective in the trinitrobenzene sulfonic acid (TNBS) model that involves the more localized rectal administration of the eliciting agent (Elliott et al., 2003). Similarly, administration of worm proteins extracted from adult schistosomes in the TNBS colitis model as much as 6 h after rectal administration of TNBS led to decreased inflammation (Ruyssers et al., 2009). The worm antigen treatment was accompanied by increased colonic expression of IL-10, TGFβ, and IL-5 but diminished expression of IFNγ, IL-12, IL-17, and IL-4 (Ruyssers et al., 2009). The epidemiological and experimental data outlined above was used as justification for Phase I open-label trials and Phase II randomized, controlled clinical trials using ingestion of ova from the pig whipworm, Trichuris suis, to treat ulcerative colitis (Summers et al., 2003, 2005). Oral intake of 2500 T. suis ova biweekly for 12 weeks led to clinical improvement in 43% of ova-treated patients compared to 17% improvement using the same measures in placebo-control recipients at the end of the 12 weeks treatment period (Summers et al., 2005). Therapy with T. suis eggs may have several advantages over similar treatment with eggs from other helminths since the T. suis eggs are easy to obtain and store, and do not permanently colonize humans or invade into tissues where they could become pathogenic (Weinstock et al., 2002).
There was an early expectation that an association of increased incidence of allergic asthma and other atopic disease responses in individuals with schistosoma infections would exist, due to the strongly skewed TH2 immune response environment induced by SEA. However, this was not the case and individuals with schistosoma infection were shown to have lower incidence of allergic asthma compared to those without (Yazdanbakhsh et al., 2001; Araujo and De Carvalho, 2006). While this effect does not appear to be limited to schistosomes, they are the most widely endemic infectious organism among helminths and the most thoroughly studied. Initial data suggested that the responses could be correlated to increased levels of IL-10 and subsequently to TREG cells that are generated during chronic schistosoma infection (Cardoso et al., 2006; Yang et al., 2007). Interestingly, recent data immunizing animals to a specific schistosome antigen, Sm22.6, demonstrated that allergen specific IgE as well as TH2 cytokines were reduced and correlated with generation of TREG cells (Cardoso et al., 2010). However, subsequent additional studies have demonstrated that numerous B cell associated responses may also contribute to a regulatory environment for the development and regulation of allergic responses, including both B cell-derived IL-10 production and altered T cell activation (Amu et al., 2010; Van Der Vlugt et al., 2012). In these studies, B cell transfer experiments demonstrated that CD1dhi B cells from schistosome-infected animals could modulate allergen-induced responses in an IL-10-dependent manner that stimulated TREG cells in the recipients (Amu et al., 2010; Van Der Vlugt et al., 2012). A similar population of CD1dhi IL-10 producing B cells was found in the peripheral blood of Schistosoma haematobium-infected Gabonese children compared to uninfected children (Van Der Vlugt et al., 2012). Importantly, in the latter study a reduction in the BREG population was reduced after treatment of the schistosome infection (Van Der Vlugt et al., 2012). In some B cell transfer studies involving cells isolated from helminth infected mice, there were also notable suppressive effects on asthma that were independent of IL-10, but the mechanisms were not determined (Wilson et al., 2010; Van Der Vlugt et al., 2012). Using animal models of chronic allergic responses it was observed that lung CD5+ B cells could express FasL and regulate allergic responses by a FasL-mediated mechanism similar to that previously observed in schistosome infection (Lundy and Boros, 2002; Lundy et al., 2005). What is not clear from these studies is how the regulated immune response controlled by B cells from schistosome infections is able to cross react to allergens and elicit non-specific regulatory functions. Interestingly, since B cells can provide a TH2-skewed APC function during allergic responses, there may also be other aspects of B cell biology that alters the direction of TH2 type allergic immune responses (Lindell et al., 2008). It is conceivable that one aspect of B cell regulation might be related to the ability to alter the cytokine environment and indirectly affect activation of regulatory T cells. Thus, the infection with Schistosoma has a systemic effect on the development of allergic responses that includes an interrelated generation of numerous regulatory lymphocyte populations, both B and T cells, that may impact several aspects of immunity including vaccination responses.
Therapeutic Potential of Schistosome-Derived Immunomodulators
A challenge moving forward with efforts to eradicate schistosomes will be to find ways of selectively replacing their potentially beneficial immune modulatory effects on allergy and autoimmunity, while preserving immune responses toward other pathogenic microorganisms. The correlations between chronic exposure to schistosome eggs and immune downregulation have led to interest in finding egg-derived molecules that can therapeutically mediate suppression of immune responses (Harnett and Harnett, 2010). It has long been recognized that SEA is a major mediator of the shift in immune response from the proinflammatory and TH1 reactions prevalent early after infection toward the TH2-dominated response that prevails in the acute phase of egg granuloma formation. SEA is a highly complex mixture of components including proteins, nucleic acids, lipids, glycolipids, complex carbohydrates, and glycoprotein molecules that can have direct or indirect effects on both innate and adaptive immune responses. Schistosome LNFPIII and glycoprotein ω-1 have been particularly interesting candidate molecules that contribute to immune modulation, yet there may be many other molecules in SEA or derived from other helminths that could hold therapeutic potential (Harnett and Harnett, 2010).
The pentameric, sialyl Lewisx containing glycan, lacto-N-fucopentaose III (LNFPIII, CD15), is a major carbohydrate component of SEA (Figure 2A). It was originally identified by antibody binding on human tumor cells and later found to be expressed by many human adult and fetal tissues, particularly in the mucosa (Brockhaus et al., 1982; Combs et al., 1984; Velupillai and Harn, 1994). As described above and shown in Figure 2B, the LNFPIII found in SEA was originally shown to have direct effects on the stimulation of IL-10 production by CD5+ B cells in vitro (Velupillai et al., 1997). LNFPIII also drives a strong TH2 response toward protein antigens with which it is conjugated when injected into mice (Okano et al., 2001; Faveeuw et al., 2002). Subcutaneous injection of a dextran-conjugated LNFPIII compound into psoriasis susceptible fsn/fsn mice prior to disease onset was shown to have a preventive effect on the formation of skin lesions (Atochina and Harn, 2006). LNFPIII has also been shown to be therapeutic in a mouse model of multiple sclerosis, and it prolonged the survival of allogeneic heart transplants in mice (Dutta et al., 2010; Zhu et al., 2012). LNFPIII skews the antigen presenting capacity of dendritic cells (DC) toward CD4+ but not CD8+ T cells (Wang et al., 2010). Treatment of spleen-derived DC from naïve mice with LNFPIII led to increases in MHC Class II and CD40 surface expression similar to the effects seen after bacterial lipopolysaccharide (LPS) treatment (Wang et al., 2010). However, LNFPIII induced higher expression of CD86 and lower expression of CD80 than LPS resulting in a dramatic difference in the ratio of these agonists for CD28 and CTLA4 molecules expressed by T cells (Wang et al., 2010). In coculture experiments, the LNFPIII treated DC preferentially induced IL-4 production from OT-II transgenic TH cells isolated from the spleens of naïve mice (Wang et al., 2010). Details of the signaling effects downstream of LNFPIII treatment in DC has recently been well reviewed (Harnett and Harnett, 2010). LNFPIII signaling is dependent on TLR4, the receptor for LPS, but downstream signaling is significantly different between the two ligands particularly in the ERK and MAP kinase pathways and the mechanism of activation of the transcription factor NFκB (Thomas et al., 2005; Wang et al., 2010). In contrast to LPS stimulation, LNFPIII signals independently of MyD88 and does not induce degradation of the inhibitor of NFκB (Thomas et al., 2005). A putative mechanism for this difference involves the binding of LNFPIII to C-type lectin receptors such as DC-specific ICAM-3 grabbing non-integrin (DC-SIGN) by the Lewisx motif (Van Liempt et al., 2004, 2007; Singh et al., 2009). It has been shown that activation of C-type lectins through binding of antibodies that are glycosylated with Lewisx containing glycans is a mechanism of immune suppression induced by IVIG treatment, a therapy for immune thrombocytopenic purpura and other diseases (Anthony et al., 2008, 2012).
Figure 2. Structure and mechanisms of action of lacto-N-fucopentaose III protein conjugates on CD5+ B cells and dendritic cells. (A) The lacto-N-fucopentaose III (LNFPIII) molecule is a pentameric glycan consisting of the trimeric sialyl Lewisx motif (green triangle) linked to a beta-galactose and glucose dimer. For in vitro and in vivo studies, the glycan conjugated proteins have been purified from soluble egg antigen (SEA) or manufactured by linkage to a carrier protein molecule (bovine serum albumin, dextran, ovalbumin) using biochemical crosslinkers. (B) LNFPIII conjugates have direct effects on proliferation and IL-10 production by CD5+ B cells. Dendritic cells (DC) respond to LNFPIII with altered antigen presenting capacity that favors TH2 induction. Activation of DC by LNFPIII is mediated through TLR4 and/or DC-SIGN, while the receptors for LNFPIII on CD5+ B cells have not yet been identified. Treatment of mice with LNFPIII protein conjugates has led to decreased disease progression in experimental autoimmune encephalomyelitis (EAE), asthma and psoriasis models, and led to prolonged heart allograft survival in a transplantation model. DC-SIGN, dendritic cell-specific intracellular adhesion molecule-3-grabbing non-integrin; TLR4, toll-like receptor 4; APC, antigen presenting cell.
In the case of treatment for autoimmune diseases that are mediated by TH1 or TH17 immune responses, it may be sufficient to skew the response toward the TH2 cytokine, IL-4, which has an inhibitory effect on IL-12 and IL-17 production. The SEA-derived T2 ribonuclease omega-1 (ω-1) has a direct effect on antigen presenting cells that supports TH2 polarization (Everts et al., 2009, 2012; Steinfelder et al., 2009). Purified and recombinant ω-1 suppressed the ability of LPS to induce IL-12 secretion from DC as well as their ability to induce IFNγ-producing TH1 cells in coculture experiments (Everts et al., 2009; Steinfelder et al., 2009). Injection of purified ω-1 into 4get/KN2 mice demonstrated that ω-1 could prime TH2 responses in vivo and further experiments showed that TH2 induction was independent of the IL-4R suggesting that the effects of ω-1 on TH2 priming were direct (Everts et al., 2009). Like LNFPIII, ω-1 is glycosylated with sialyl Lewisx motifs, and the TH2 inducing capacity of ω-1 was shown to be dependent on glycosylation as well as the ribonuclease activity of the protein (Meevissen et al., 2010; Everts et al., 2012). Treatment of DC with SEA or purified ω-1 glycoprotein caused changes to the adherence of DC to plastic dishes and disrupted interactions with antigen-specific TH cells (Steinfelder et al., 2009). Antibody neutralization and studies performed in mice with deficiencies in the mannose receptor indicated that ω-1 was dependent on the mannose receptor, but not on DC-SIGN, for uptake into DC in vitro and TH2 polarization in vivo (Everts et al., 2012). Treatment of NOD mice with ω-1 led to global increases in the proportion of TH1, TH17, and TH2 cells compared to untreated control mice, as well as a marked induction of FoxP3+CTLA4+ TREG cells (Zaccone et al., 2011). The induction of FoxP3 expression by ω-1 was dependent on the functions of TGFβ and retinoic acid (Zaccone et al., 2011). It has not been reported whether treatment with ω-1 causes reduced or delayed development of diabetes in the NOD mice. Thus, both the glycoprotein ω-1 and the glycan LNFPIII components purified from SEA have demonstrable effects on adaptive immune parameters making each molecule a strong candidate for development of helminth-based immune therapeutics.
Summary and Concluding Remarks
Although nearly every person may have been expected to be infected by a helminth in their lifetime just a century ago, heroic eradication efforts have all but eliminated helminth infection from many areas and brought the infection rate down to an estimated 10–20% of people worldwide. This has led to vast improvements in the quality of life for billions of people, and will have great benefits for combatting other major infections. Several regulatory populations of lymphocytes are activated as the infection becomes chronic and these diminish the responses of schistosome antigen-specific effector T helper cells, and limit granuloma formation around newly deposited eggs. The chronic nature of schistosome-induced immune modulation can also affect immune responses toward other antigen sources, leading to poorer reactions to subsequent infections by other microbes. Also accompanying the shift in worm infection rates have been measurable increases in the rates of hyper-inflammatory diseases including allergies, asthma, and many autoimmune diseases. Chronic helminth infections may drive immune suppression toward allergens and self-antigens, thus potentially explaining the lower incidence of allergies, asthma and autoimmunity in schistosome endemic areas. Studies of the cellular and molecular mechanisms underlying schistosome-induced immune suppression in mice have supported the importance of regulatory T lymphocytes and the effector cytokine TGFβ as mediators of suppression. The schistosome infection model has also been instrumental in the discovery of immune regulatory functions of B cells including IL-10 production, and expression of the death-inducing molecule Fas ligand. IL-10-producing B cells may mediate cooperative effects with regulatory T cells, while FasL+ B cells have been shown to have antigen-specific killer effects on T helper cells in models of asthma and autoimmunity. The data from adoptive cell transfer studies gives striking evidence that schistosomes do have cross-regulatory effects on autoimmunity and asthma. The goal as we move forward will be to find ways to mimic or replace the protective aspects of helminth infections, while continuing to improve hygienic conditions in endemic areas.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abdulla, M. H., Lim, K. C., Mckerrow, J. H., and Caffrey, C. R. (2011). Proteomic identification of IPSE/alpha-1 as a major hepatotoxin secreted by Schistosoma mansoni eggs. PLoS Negl. Trop. Dis. 5:e1368. doi: 10.1371/journal.pntd.0001368
Airaghi, L., and Tedeschi, A. (2004). Results of the US Third National Health and Nutrition Examination Survey support the hygiene hypothesis. J. Allergy Clin. Immunol. 113, 179–180. author reply: 180.
Amu, S., Saunders, S. P., Kronenberg, M., Mangan, N. E., Atzberger, A., and Fallon, P. G. (2010). Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125, 1114.e8–1124.e8.
Angelico, M., Renganathan, E., Gandin, C., Fathy, M., Profili, M. C., Refai, W., et al. (1997). Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J. Hepatol. 26, 236–243.
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., and Ravetch, J. V. (2008). Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320, 373–376.
Araujo, M. I., Hoppe, B. S., Medeiros, M. Jr., and Carvalho, E. M. (2004). Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem. Inst. Oswaldo Cruz 99, 27–32.
Baumgart, M., Tompkins, F., Leng, J., and Hesse, M. (2006). Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J. Immunol. 176, 5374–5387.
Blair, P. A., Norena, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., et al. (2010). CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32, 129–140.
Boros, D. L., Amsden, A. F., and Hood, A. T. (1982). Modulation of granulomatous hypersensitivity. IV. Immunoglobulin and antibody production by vigorous and immunomodulated liver granulomas of Schistosoma mansoni-infected mice. J. Immunol. 128, 1050–1053.
Boros, D. L., and Warren, K. S. (1970). Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132, 488–507.
Boros, D. L., and Warren, K. S. (1971a). Effect of antimacrophage serum on hypersensitivity (Schistosoma mansoni egg) and foreign body (divinyl-benzene copolymer bead) granulomas. J. Immunol. 107, 534–539.
Boros, D. L., and Warren, K. S. (1971b). Specific granulomatous hypersensitivity elicited by bentonite particles coated with soluble antigens from schistosome eggs and turcle bacilli. Nature 229, 200–201.
Boros, D. L., and Whitfield, J. R. (1998). Endogenous IL-10 regulates IFN-gamma and IL-5 cytokine production and the granulomatous response in Schistosomiasis mansoni-infected mice. Immunology 94, 481–487.
Brockhaus, M., Magnani, J. L., Herlyn, M., Blaszczyk, M., Steplewski, Z., Koprowski, H., et al. (1982). Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors. Arch. Biochem. Biophys. 217, 647–651.
Brown, M., Miiro, G., Nkurunziza, P., Watera, C., Quigley, M. A., Dunne, D. W., et al. (2006). Schistosoma mansoni, nematode infections, and progression to active tuberculosis among HIV-1-infected Ugandans. Am. J. Trop. Med. Hyg. 74, 819–825.
Brunet, L. R., Sabin, E. A., Cheever, A. W., Kopf, M. A., and Pearce, E. J. (1999). Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine Schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells. Infect. Immun. 67, 3014–3018.
Burke, M. L., McManus, D. P., Ramm, G. A., Duke, M., Li, Y., Jones, M. K., et al. (2010). Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl. Trop. Dis. 4:e598. doi: 10.1371/journal.pntd.0000598
Cai, Y., Langley, J. G., Smith, D. I., and Boros, D. L. (1996). A cloned major Schistosoma mansoni egg antigen with homologies to small heat shock proteins elicits Th1 responsiveness. Infect. Immun. 64, 1750–1755.
Cardoso, L. S., Oliveira, S. C., Goes, A. M., Oliveira, R. R., Pacifico, L. G., Marinho, F. V., et al. (2010). Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin. Exp. Immunol. 160, 266–274.
Cardoso, L. S., Oliveira, S. C., Pacifico, L. G., Goes, A. M., Oliveira, R. R., Fonseca, C. T., et al. (2006). Schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals. Mem. Inst. Oswaldo Cruz 101(Suppl. 1), 339–343.
Carneiro-Santos, P., Martins-Filho, O., Alves-Oliveira, L. F., Silveira, A. M., Coura-Filho, P., Viana, I. R., et al. (2000). Apoptosis: a mechanism of immunoregulation during human Schistosomiasis mansoni. Parasite Immunol. 22, 267–277.
Cheever, A. W., Byram, J. E., Hieny, S., Von Lichtenberg, F., Lunde, M. N., and Sher, A. (1985). Immunopathology of Schistosoma japonicum and S. mansoni infection in B cell depleted mice. Parasite Immunol. 7, 399–413.
Cheever, A. W., Williams, M. E., Wynn, T. A., Finkelman, F. D., Seder, R. A., Cox, T. M., et al. (1994). Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153, 753–759.
Chen, Y., and Boros, D. L. (1998). Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine Schistosomiasis mansoni. J. Immunol. 160, 5420–5427.
Chen, Y., and Boros, D. L. (2001). The Schistosoma mansoni egg-derived r38 peptide-induced Th1 response affects the synchronous pulmonary but not the asynchronous hepatic granuloma growth. Parasite Immunol. 23, 43–50.
Chen, Y., Khanna, S., Goodyear, C. S., Park, Y. B., Raz, E., Thiel, S., et al. (2009). Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 183, 1346–1359.
Chensue, S. W., and Boros, D. L. (1979). Modulation of granulomatous hypersensitivity. I. Characterization of T lymphocytes involved in the adoptive suppression of granuloma formation in Schistosoma mansoni-infected mice. J. Immunol. 123, 1409–1414.
Chensue, S. W., Wellhausen, S. R., and Boros, D. L. (1981). Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J. Immunol. 127, 363–367.
Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., and Wynn, T. A. (1999a). An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104, 777–785.
Chiaramonte, M. G., Schopf, L. R., Neben, T. Y., Cheever, A. W., Donaldson, D. D., and Wynn, T. A. (1999b). IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162, 920–930.
Combs, S. G., Marder, R. J., Minna, J. D., Mulshine, J. L., Polovina, M. R., and Rosen, S. T. (1984). Immunohistochemical localization of the immunodominant differentiation antigen lacto-N-fucopentaose III in normal adult and fetal tissues. J. Histochem. Cytochem. 32, 982–988.
Cooke, A., Tonks, P., Jones, F. M., O'Shea, H., Hutchings, P., Fulford, A. J., et al. (1999). Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21, 169–176.
Dewals, B. G., Marillier, R. G., Hoving, J. C., Leeto, M., Schwegmann, A., and Brombacher, F. (2010). IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness. PLoS Negl. Trop. Dis. 4:e689. doi: 10.1371/journal.pntd.0000689
Dunne, D. W., Jones, F. M., and Doenhoff, M. J. (1991). The purification, characterization, serological activity and hepatotoxic properties of two cationic glycoproteins (alpha 1 and omega 1) from Schistosoma mansoni eggs. Parasitology 103(Pt 2), 225–236.
Dutta, P., Hullett, D. A., Roenneburg, D. A., Torrealba, J. R., Sollinger, H. W., Harn, D. A., et al. (2010). Lacto-N-fucopentaose III, a pentasaccharide, prolongs heart transplant survival. Transplantation 90, 1071–1078.
Edwards, M. J., Buchatska, O., Ashton, M., Montoya, M., Bickle, Q. D., and Borrow, P. (2005). Reciprocal immunomodulation in a schistosome and hepatotropic virus coinfection model. J. Immunol. 175, 6275–6285.
El-Cheikh, M. C., Bonomo, A. C., Rossi, M. I., Pinho Mde, F., and Borojevic, R. (1998). Experimental murine Schistosomiasis mansoni: modulation of the B-1 lymphocyte distribution and phenotype expression. Immunobiology 199, 51–62.
Elias, D., Akuffo, H., Thors, C., Pawlowski, A., and Britton, S. (2005). Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin. Exp. Immunol. 139, 398–404.
El-Kady, I. M., Lotfy, M., Badra, G., El-Masry, S., and Waked, I. (2005). Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections. Scand. J. Immunol. 61, 87–91.
Elliott, D. E., and Boros, D. L. (1984). Schistosome egg antigen(s) presentation and regulatory activity by macrophages isolated from vigorous or immunomodulated liver granulomas of Schistosoma mansoni-infected mice. J. Immunol. 132, 1506–1510.
Elliott, D. E., Li, J., Blum, A., Metwali, A., Qadir, K., Urban, J. F., et al. (2003). Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G385–G391.
Elliott, D. E., Ragheb, S., Wellhausen, S. R., and Boros, D. L. (1990). Interactions between adherent mononuclear cells and lymphocytes from granulomas of mice with Schistosomiasis mansoni. Infect. Immun. 58, 1577–1583.
Elliott, D. E., Righthand, V. F., and Boros, D. L. (1987). Characterization of regulatory (interferon-alpha/beta) and accessory (LAF/IL 1) monokine activities from liver granuloma macrophages of Schistosoma mansoni-infected mice. J. Immunol. 138, 2653–2662.
Estaquier, J., Marguerite, M., Sahuc, F., Bessis, N., Auriault, C., and Ameisen, J. C. (1997). Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur. Cytokine Netw. 8, 153–160.
Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R., et al. (2007). Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178, 7868–7878.
Everts, B., Hussaarts, L., Driessen, N. N., Meevissen, M. H., Schramm, G., van der Ham, A. J., et al. (2012). Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J. Exp. Med. 209, 1753–1767.
Everts, B., Perona-Wright, G., Smits, H. H., Hokke, C. H., van der Ham, A. J., Fitzsimmons, C. M., et al. (2009). Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J. Exp. Med. 206, 1673–1680.
Falcone, F. H., Dahinden, C. A., Gibbs, B. F., Noll, T., Amon, U., Hebestreit, H., et al. (1996). Human basophils release interleukin-4 after stimulation with Schistosoma mansoni egg antigen. Eur. J. Immunol. 26, 1147–1155.
Fallon, P. G., and Dunne, D. W. (1999). Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. J. Immunol. 162, 4122–4132.
Fallon, P. G., Richardson, E. J., McKenzie, G. J., and McKenzie, A. N. (2000a). Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164, 2585–2591.
Fallon, P. G., Richardson, E. J., Smith, P., and Dunne, D. W. (2000b). Elevated type 1, diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice. Eur. J. Immunol. 30, 470–480.
Farghaly, A. G., and Barakat, R. M. (1993). The effect of praziquantel administration on the course of hepatitis B among cases with concomitant schistosome infection. J. Egypt. Public Health Assoc. 68, 81–100.
Faveeuw, C., Angeli, V., Fontaine, J., Maliszewski, C., Capron, A., Van Kaer, L., et al. (2002). Antigen presentation by CD1d contributes to the amplification of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J. Immunol. 169, 906–912.
Ferru, I., Roye, O., Delacre, M., Auriault, C., and Wolowczuk, I. (1998). Infection of B-cell-deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation. Scand. J. Immunol. 48, 233–240.
Fidel, P. L. Jr., and Boros, D. L. (1990). Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production. J. Immunol. 145, 1257–1264.
Flores Villanueva, P. O., Chikunguwo, S. M., Harris, T. S., and Stadecker, M. J. (1993). Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J. Immunol. 151, 3192–3198.
Flores-Villanueva, P. O., Zheng, X. X., Strom, T. B., and Stadecker, M. J. (1996). Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 156, 3315–3320.
Frantz, F. G., Rosada, R. S., Peres-Buzalaf, C., Perusso, F. R., Rodrigues, V., Ramos, S. G., et al. (2010). Helminth coinfection does not affect therapeutic effect of a DNA vaccine in mice harboring tuberculosis. PLoS Negl. Trop. Dis. 4:e700. doi: 10.1371/journal.pntd.0000700
Gaubert, S., Viana da Costa, A., Maurage, C. A., Lima, E. C., Fontaine, J., Lafitte, S., et al. (1999). X-linked immunodeficiency affects the outcome of Schistosoma mansoni infection in the murine model. Parasite Immunol. 21, 89–101.
Glocker, E. O., Kotlarz, D., Boztug, K., Gertz, E. M., Schaffer, A. A., Noyan, F., et al. (2009). Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033–2045.
Goes, A. M., Gazzinelli, G., Rocha, R., Katz, N., and Doughty, B. L. (1991). Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. III. In vitro granuloma modulation induced by immune complexes. Am. J. Trop. Med. Hyg. 44, 434–443.
Hernandez, H. J., Wang, Y., and Stadecker, M. J. (1997). In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation. J. Immunol. 158, 4832–4837.
Hoffmann, K. F., Cheever, A. W., and Wynn, T. A. (2000). IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164, 6406–6416.
Iwata, Y., Matsushita, T., Horikawa, M., Dilillo, D. J., Yanaba, K., Venturi, G. M., et al. (2011). Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530–541.
Jankovic, D., Cheever, A. W., Kullberg, M. C., Wynn, T. A., Yap, G., Caspar, P., et al. (1998). CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J. Exp. Med. 187, 619–629.
Jankovic, D., Kullberg, M. C., Dombrowicz, D., Barbieri, S., Caspar, P., Wynn, T. A., et al. (1997). Fc epsilonRI-deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology. J. Immunol. 159, 1868–1875.
Jankovic, D., Kullberg, M. C., Noben-Trauth, N., Caspar, P., Ward, J. M., Cheever, A. W., et al. (1999). Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 163, 337–342.
Kallestrup, P., Zinyama, R., Gomo, E., Butterworth, A. E., Mudenge, B., van Dam, G. J., et al. (2005). Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J. Infect. Dis. 192, 1956–1961.
Kamal, S. M., Bianchi, L., Al Tawil, A., Koziel, M., El Sayed Khalifa, K., Peter, T., et al. (2001). Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J. Infect. Dis. 184, 972–982.
Kamal, S. M., Graham, C. S., He, Q., Bianchi, L., Tawil, A. A., Rasenack, J. W., et al. (2004). Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J. Infect. Dis. 189, 1140–1150.
Kullberg, M. C., Berzofsky, J. A., Jankovic, D. L., Barbieri, S., Williams, M. E., Perlmann, P., et al. (1996). T cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice. J. Immunol. 156, 1482–1489.
La Flamme, A. C., Ruddenklau, K., and Backstrom, B. T. (2003). Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect. Immun. 71, 4996–5004.
Larouze, B., Dazza, M. C., Gaudebout, C., Habib, M., Elamy, M., and Cline, B. (1987). Absence of relationship between Schistosoma mansoni and hepatitis B virus infection in the Qalyub Governate, Egypt. Ann. Trop. Med. Parasitol. 81, 373–375.
Lawn, S. D., Karanja, D. M., Mwinzia, P., Andove, J., Colley, D. G., Folks, T. M., et al. (2000). The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS 14, 2437–2443.
Layland, L. E., Mages, J., Loddenkemper, C., Hoerauf, A., Wagner, H., Lang, R., et al. (2010). Pronounced phenotype in activated regulatory T cells during a chronic helminth infection. J. Immunol. 184, 713–724.
Lindell, D. M., Berlin, A. A., Schaller, M. A., and Lukacs, N. W. (2008). B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. PLoS ONE 3:e3129. doi: 10.1371/journal.pone.0003129
Liu, J. Y., Li, L. Y., Yang, X. Z., Li, J., Zhong, G., Wang, J., et al. (2011). Adoptive transfer of dendritic cells isolated from helminth-infected mice enhanced T regulatory cell responses in airway allergic inflammation. Parasite Immunol. 33, 525–534.
Lucas, S., Musallam, R., Bain, J., Hassounah, O., Bickle, Q., and Doenhoff, M. (1980). The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetate. Trans. R. Soc. Trop. Med. Hyg. 74, 633–643.
Lukacs, N. W., and Boros, D. L. (1991). Identification of larval cross-reactive and egg-specific antigens involved in granuloma formation in murine Schistosomiasis mansoni. Infect. Immun. 59, 3237–3242.
Lukacs, N. W., and Boros, D. L. (1992). Utilization of fractionated soluble egg antigens reveals selectively modulated granulomatous and lymphokine responses during murine Schistosomiasis mansoni. Infect. Immun. 60, 3209–3216.
Lukacs, N. W., Kunkel, S. L., Strieter, R. M., Warmington, K., and Chensue, S. W. (1993). The role of macrophage inflammatory protein 1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177, 1551–1559.
Lundy, S. K., and Boros, D. L. (2002). Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect. Immun. 70, 812–819.
Lundy, S. K., Lerman, S. P., and Boros, D. L. (2001). Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect. Immun. 69, 271–280.
Mathew, R. C., and Boros, D. L. (1986). Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect. Immun. 54, 820–826.
McElroy, M. D., Elrefaei, M., Jones, N., Ssali, F., Mugyenyi, P., Barugahare, B., et al. (2005). Coinfection with Schistosoma mansoni is associated with decreased HIV-specific cytolysis and increased IL-10 production. J. Immunol. 174, 5119–5123.
McKenzie, G. J., Fallon, P. G., Emson, C. L., Grencis, R. K., and McKenzie, A. N. (1999). Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189, 1565–1572.
Meevissen, M. H., Wuhrer, M., Doenhoff, M. J., Schramm, G., Haas, H., Deelder, A. M., et al. (2010). Structural characterization of glycans on omega-1, a major Schistosoma mansoni egg glycoprotein that drives Th2 responses. J. Proteome Res. 9, 2630–2642.
Metwali, A., Elliott, D., Blum, A. M., Li, J., Sandor, M., Lynch, R., et al. (1996). The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J. Immunol. 157, 4546–4553.
Milner, T., Reilly, L., Nausch, N., Midzi, N., Mduluza, T., Maizels, R., et al. (2010). Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Parasite Immunol. 32, 710–721.
Mwatha, J. K., Kimani, G., Kamau, T., Mbugua, G. G., Ouma, J. H., Mumo, J., et al. (1998). High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human Schistosomiasis mansoni. J. Immunol. 160, 1992–1999.
Nacher, M., Singhasivanon, P., Traore, B., Vannaphan, S., Gay, F., Chindanond, D., et al. (2002a). Helminth infections are associated with protection from cerebral malaria and increased nitrogen derivatives concentrations in Thailand. Am. J. Trop. Med. Hyg. 66, 304–309.
Nacher, M., Singhasivanon, P., Yimsamran, S., Manibunyong, W., Thanyavanich, N., Wuthisen, R., et al. (2002b). Intestinal helminth infections are associated with increased incidence of Plasmodium falciparum malaria in Thailand. J. Parasitol. 88, 55–58.
Okano, M., Satoskar, A. R., Nishizaki, K., and Harn, D. A. Jr. (2001). Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J. Immunol. 167, 442–450.
Osada, Y., Shimizu, S., Kumagai, T., Yamada, S., and Kanazawa, T. (2009). Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int. J. Parasitol. 39, 457–464.
Oswald, I. P., Gazzinelli, R. T., Sher, A., and James, S. L. (1992a). IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148, 3578–3582.
Oswald, I. P., Wynn, T. A., Sher, A., and James, S. L. (1992b). Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. U.S.A. 89, 8676–8680.
Pacifico, L. G., Marinho, F. A., Fonseca, C. T., Barsante, M. M., Pinho, V., Sales-Junior, P. A., et al. (2009). Schistosoma mansoni antigens modulate experimental allergic asthma in a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of interleukin-10. Infect. Immun. 77, 98–107.
Perrigoue, J. G., Saenz, S. A., Siracusa, M. C., Allenspach, E. J., Taylor, B. C., Giacomin, P. R., et al. (2009). MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat. Immunol. 10, 697–705.
Phillips, S. M., Diconza, J. J., Gold, J. A., and Reid, W. A. (1977). Schistosomiasis in the congenitally athymic (nude) mouse. I. Thymic dependency of eosinophilia, granuloma formation, and host morbidity. J. Immunol. 118, 594–599.
Qadir, K., Metwali, A., Blum, A. M., Li, J., Elliott, D. E., and Weinstock, J. V. (2001). TGF-beta and IL-10 regulation of IFN-gamma produced in Th2-type schistosome granulomas requires IL-12. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G940–G946.
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., et al. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 342, 921–929.
Rakasz, E., Blum, A. M., Metwali, A., Elliott, D. E., Li, J., Ballas, Z. K., et al. (1998). Localization and regulation of IFN-gamma production within the granulomas of murine schistosomiasis in IL-4-deficient and control mice. J. Immunol. 160, 4994–4999.
Reis, E. A., Mauadi Carmo, T. A., Athanazio, R., Reis, M. G., and Harn, D. A. Jr. (2008). Schistosoma mansoni triose phosphate isomerase peptide MAP4 is able to trigger naive donor immune response towards a type-1 cytokine profile. Scand. J. Immunol. 68, 169–176.
Rezende, S. A., Gollob, K. J., Correa-Oliveira, R., and Goes, A. M. (1998). Down modulation of MHC surface molecules on B cells by suppressive immune complexes obtained from chronic intestinal schistosomiasis patients. Immunol. Lett. 62, 67–73.
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., et al. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546–558.
Rumbley, C. A., Sugaya, H., Zekavat, S. A., El Refaei, M., Perrin, P. J., and Phillips, S. M. (1999). Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J. Immunol. 162, 1003–1009.
Rutitzky, L. I., Bazzone, L., Shainheit, M. G., Joyce-Shaikh, B., Cua, D. J., and Stadecker, M. J. (2008). IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J. Immunol. 180, 2486–2495.
Rutitzky, L. I., Lopes da Rosa, J. R., and Stadecker, M. J. (2005). Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 175, 3920–3926.
Rutitzky, L. I., Smith, P. M., and Stadecker, M. J. (2009). T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation. Eur. J. Immunol. 39, 2470–2481.
Rutitzky, L. I., and Stadecker, M. J. (2011). Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-gamma. Eur. J. Immunol. 41, 2677–2687.
Ruyssers, N. E., De Winter, B. Y., De Man, J. G., Loukas, A., Pearson, M. S., Weinstock, J. V., et al. (2009). Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm. Bowel Dis. 15, 491–500.
Sabin, E. A., Araujo, M. I., Carvalho, E. M., and Pearce, E. J. (1996a). Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173, 269–272.
Sabin, E. A., and Pearce, E. J. (1995). Early IL-4 production by non-CD4+ cells at the site of antigen deposition predicts the development of a T helper 2 cell response to Schistosoma mansoni eggs. J. Immunol. 155, 4844–4853.
Sacco, R., Hagen, M., Sandor, M., Weinstock, J. V., and Lynch, R. G. (2002). Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin. Immunol. 104, 274–281.
Schramm, G., Mohrs, K., Wodrich, M., Doenhoff, M. J., Pearce, E. J., Haas, H., et al. (2007). Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo. J. Immunol. 178, 6023–6027.
Secor, W. E., Shah, A., Mwinzi, P. M., Ndenga, B. A., Watta, C. O., and Karanja, D. M. (2003). Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection. Infect. Immun. 71, 6668–6671.
Sewell, D., Qing, Z., Reinke, E., Elliot, D., Weinstock, J., Sandor, M., et al. (2003). Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int. Immunol. 15, 59–69.
Shainheit, M. G., Smith, P. M., Bazzone, L. E., Wang, A. C., Rutitzky, L. I., and Stadecker, M. J. (2008). Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology. J. Immunol. 181, 8559–8567.
Shapira-Nahor, O., Kalinkovich, A., Weisman, Z., Greenberg, Z., Nahmias, J., Shapiro, M., et al. (1998). Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 12, 1731–1733.
Sher, A., Coffman, R. L., Hieny, S., Scott, P., and Cheever, A. W. (1990). Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. U.S.A. 87, 61–65.
Sher, A., Fiorentino, D., Caspar, P., Pearce, E., and Mosmann, T. (1991). Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147, 2713–2716.
Singh, K. P., Gerard, H. C., Hudson, A. P., Reddy, T. R., and Boros, D. L. (2005). Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice. Immunology 114, 410–417.
Singh, S. K., Stephani, J., Schaefer, M., Kalay, H., Garcia-Vallejo, J. J., Den Haan, J., et al. (2009). Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol. Immunol. 47, 164–174.
Smith, P., Mangan, N. E., Walsh, C. M., Fallon, R. E., McKenzie, A. N., van Rooijen, N., et al. (2007). Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J. Immunol. 178, 4557–4566.
Sokhna, C., Le Hesran, J. Y., Mbaye, P. A., Akiana, J., Camara, P., Diop, M., et al. (2004). Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malar. J. 3:43. doi: 10.1186/1475-2875-3-43
Sokol, C. L., Chu, N. Q., Yu, S., Nish, S. A., Laufer, T. M., and Medzhitov, R. (2009). Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol. 10, 713–720.
Song, X., Shen, J., Wen, H., Zhong, Z., Luo, Q., Chu, D., et al. (2011). Impact of Schistosoma japonicum infection on collagen-induced arthritis in DBA/1 mice: a murine model of human rheumatoid arthritis. PLoS ONE 6:e23453. doi: 10.1371/journal.pone.0023453
Steinfelder, S., Andersen, J. F., Cannons, J. L., Feng, C. G., Joshi, M., Dwyer, D., et al. (2009). The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J. Exp. Med. 206, 1681–1690.
Summers, R. W., Elliott, D. E., Qadir, K., Urban, J. F. Jr., Thompson, R., and Weinstock, J. V. (2003). Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 98, 2034–2041.
Summers, R. W., Elliott, D. E., Urban, J. F. Jr., Thompson, R. A., and Weinstock, J. V. (2005). Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128, 825–832.
Taylor, J. J., Mohrs, M., and Pearce, E. J. (2006). Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 176, 5839–5847.
Terrazas, L. I., Walsh, K. L., Piskorska, D., McGuire, E., and Harn, D. A. Jr. (2001). The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections. J. Immunol. 167, 5294–5303.
Thomas, P. G., Carter, M. R., Da'dara, A. A., Desimone, T. M., and Harn, D. A. (2005). A helminth glycan induces APC maturation via alternative NF-kappa B activation independent of I kappa B alpha degradation. J. Immunol. 175, 2082–2090.
Todt, J. C., Whitfield, J. R., Ivard, S. R., and Boros, D. L. (2000). Down-regulation of interleukin-12, interleukin-12R expression/activity mediates the switch from Th1 to Th2 granuloma response during murine Schistosomiasis mansoni. Scand. J. Immunol. 52, 385–392.
Van Der Vlugt, L. E., Labuda, L. A., Ozir-Fazalalikhan, A., Lievers, E., Gloudemans, A. K., Liu, K. Y., et al. (2012). Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS ONE 7:e30883. doi: 10.1371/journal.pone.0030883
Van Liempt, E., Imberty, A., Bank, C. M., Van Vliet, S. J., Van Kooyk, Y., Geijtenbeek, T. B., et al. (2004). Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens. J. Biol. Chem. 279, 33161–33167.
Van Liempt, E., Van Vliet, S. J., Engering, A., Garcia Vallejo, J. J., Bank, C. M., Sanchez-Hernandez, M., et al. (2007). Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 44, 2605–2615.
Vas, J., Gronwall, C., Marshak-Rothstein, A., and Silverman, G. J. (2012). Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum. 64, 3388–3398.
Velupillai, P., and Harn, D. A. (1994). Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc. Natl. Acad. Sci. U.S.A. 91, 18–22.
Velupillai, P., Posey, C., Horauf, A. M., Solbach, W., Piessens, W. F., and Harn, D. A. (1996a). B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp. Parasitol. 84, 168–177.
Velupillai, P., Secor, W. E., Horauf, A. M., and Harn, D. A. (1997). B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J. Immunol. 158, 338–344.
Waknine-Grinberg, J. H., Gold, D., Ohayon, A., Flescher, E., Heyfets, A., Doenhoff, M. J., et al. (2010). Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malar. J. 9:5. doi: 10.1186/1475-2875-9-5
Wang, Y., Da'dara, A. A., Thomas, P. G., and Harn, D. A. (2010). Dendritic cells activated by an anti-inflammatory agent induce CD4(+) T helper type 2 responses without impairing CD8(+) memory and effector cytotoxic T-lymphocyte responses. Immunology 129, 406–417.
Weinstock, J. V., and Boros, D. L. (1983). Modulation of granulomatous hypersensitivity. VI. T lymphocyte subsets influence mast cell density in liver granulomas of Schistosoma mansoni-infected mice. J. Immunol. 131, 959–961.
Weinstock, J. V., Summers, R. W., Elliott, D. E., Qadir, K., Urban, J. F. Jr., and Thompson, R. (2002). The possible link between de-worming and the emergence of immunological disease. J. Lab. Clin. Med. 139, 334–338.
Weng, M., Huntley, D., Huang, I. F., Foye-Jackson, O., Wang, L., Sarkissian, A., et al. (2007). Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis. J. Immunol. 179, 4721–4731.
Williams, M. E., Kullberg, M. C., Barbieri, S., Caspar, P., Berzofsky, J. A., Seder, R. A., et al. (1993). Fc epsilon receptor-positive cells are a major source of antigen-induced interleukin-4 in spleens of mice infected with Schistosoma mansoni. Eur. J. Immunol. 23, 1910–1916.
Wilson, M. S., Taylor, M. D., O'Gorman, M. T., Balic, A., Barr, T. A., Filbey, K., et al. (2010). Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40, 1682–1696.
Wolday, D., Mayaan, S., Mariam, Z. G., Berhe, N., Seboxa, T., Britton, S., et al. (2002). Treatment of intestinal worms is associated with decreased HIV plasma viral load. J. Acquir. Immune Defic. Syndr. 31, 56–62.
Wynn, T. A., Cheever, A. W., Williams, M. E., Hieny, S., Caspar, P., Kuhn, R., et al. (1998). IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 160, 4473–4480.
Wynn, T. A., Eltoum, I., Cheever, A. W., Lewis, F. A., Gause, W. C., and Sher, A. (1993). Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 151, 1430–1440.
Wynn, T. A., Eltoum, I., Oswald, I. P., Cheever, A. W., and Sher, A. (1994). Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179, 1551–1561.
Wynn, T. A., Jankovic, D., Hieny, S., Zioncheck, K., Jardieu, P., Cheever, A. W., et al. (1995). IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. J. Immunol. 154, 3999–4009.
Wynn, T. A., Morawetz, R., Scharton-Kersten, T., Hieny, S., Morse, H. C. 3rd., Kuhn, R., et al. (1997). Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159, 5014–5023.
Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M., and Tedder, T. F. (2008). A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28, 639–650.
Yang, J., Zhao, J., Yang, Y., Zhang, L., Yang, X., Zhu, X., et al. (2007). Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma. Immunology 120, 8–18.
Yap, G., Cheever, A., Caspar, P., Jankovic, D., and Sher, A. (1997). Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni. Infect. Immun. 65, 2583–2586.
Yazdanbakhsh, M., Van den Biggelaar, A., and Maizels, R. M. (2001). Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol. 22, 372–377.
Yoshimoto, T., Yasuda, K., Tanaka, H., Nakahira, M., Imai, Y., Fujimori, Y., et al. (2009). Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat. Immunol. 10, 706–712.
Zaccone, P., Burton, O., Miller, N., Jones, F. M., Dunne, D. W., and Cooke, A. (2009). Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur. J. Immunol. 39, 1098–1107.
Zaccone, P., Burton, O. T., Gibbs, S. E., Miller, N., Jones, F. M., Schramm, G., et al. (2011). The, S. mansoni glycoprotein omega-1 induces Foxp3 expression in NOD mouse CD4(+) T cells. Eur. J. Immunol. 41, 2709–2718.
Zaccone, P., Fehervari, Z., Jones, F. M., Sidobre, S., Kronenberg, M., Dunne, D. W., et al. (2003). Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33, 1439–1449.
Zheng, X., Hu, X., Zhou, G., Lu, Z., Qiu, W., Bao, J., et al. (2008). Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J. Neuroimmunol. 194, 107–114.
Zhu, B., Trikudanathan, S., Zozulya, A. L., Sandoval-Garcia, C., Kennedy, J. K., Atochina, O., et al. (2012). Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis. Clin. Immunol. 142, 351–361.
Keywords: T helper lymphocytes, immune regulation, hygiene hypothesis, soluble egg antigen, sialyl Lewisx glycans
Citation: Lundy SK and Lukacs NW (2013) Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front. Immun. 4:39. doi: 10.3389/fimmu.2013.00039
Received: 31 October 2012; Paper pending published: 05 December 2012;
Accepted: 31 January 2013; Published online: 20 February 2013.
Edited by:Dov L. Boros, Wayne State University School of Medicine, USA
Reviewed by:Michael Kracht, Justus-Liebig-University Giessen, Germany
Takayuki Yoshimoto, Tokyo Medical University, Japan
Copyright © 2013 Lundy and Lukacs. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
*Correspondence: Steven K. Lundy, Department of Internal Medicine-Rheumatology, University of Michigan Medical School, 4043 A. Alfred Taubman BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA. e-mail: email@example.com